iSelect Fund
  • Portfolio
  • Team
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Food is Health
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Insights
  • Contact
  • My iSelect
    • My iSelect Login
Select Page
iSelect Portfolio Overview and Opportunities – August 2019

iSelect Portfolio Overview and Opportunities – August 2019

  iSelect has to-date made more than 45 investments, supporting innovative companies in industries including agriculture, healthcare, software and more. We focus on the critical issues that are both facing large, global markets and come with a financially... Read more
iSelect Portfolio Overview and Opportunities – June 2019

iSelect Portfolio Overview and Opportunities – June 2019

In June, we discussed Bonumose and Shield Diagnostics and learned how both companies are innovating how we approach our health. On the one hand, Bonumose is reducing the use of unhealthy sugars in our food whereas Shield Diagnostics is preventing antibiotic... Read more
iSelect Portfolio Overview and Opportunities – June 2019

iSelect Portfolio Overview and Opportunities – April 2019

In April, we heard from two companies that are elevating the current conversation in healthcare — Holobiome and Cocoon Biotech. They are both creating new industries, bringing additional value to the marketplace, and increasing the quality of healthcare while at... Read more
Next Entries »

Related Posts

  • iSelect Fund
    iSelect Portfolio Update Webinar
  • Dan Schaub
    iSelect Video: How iSelect Fits Into the Marketplace
  • startup capital shortfall
    Startup Ecosystems
AgTechFund BLOG SIDEBAR

(314) 219-8688

7750 Maryland Ave
Box 11826
St. Louis, MO 63105

Crunchbase   Twitter   LinkedIn   Facebook   YouTube

Securities offered through North Capital Private Securities ("NCPS"), Member FINRA/SIPC, located at 623 East Ft. Union Blvd, Suite 101, Salt Lake City, UT 84047. NCPS does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform.  Please review North Capital’s Form CRS and its background on FINRA’s BrokerCheck.  Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results.  All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.